Clinical Trials Directory

Trials / Sponsors / Fore Biotherapeutics

Fore Biotherapeutics

Industry · 7 registered clinical trials — 1 currently recruiting.

StatusTrialPhaseStarted
CompletedA Study of the Effects of Food and Cobicistat on Plixorafenib Pharmacokinetics in Healthy Participants.
Healthy Participants
Phase 12024-04-24
RecruitingA Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations
Cancer Harboring BRAF Alterations, HGG, LGG
Phase 22023-02-21
CompletedA Study of FORE8394 as a Single Agent in Patients With Advanced Unresectable Solid Tumors
Advanced Unresectable Solid Tumors, BRAF-mutated Tumors
Phase 1 / Phase 22015-04-01
CompletedNovellusDx Functional Profiling of Oncogenic Mutations in Lung Cancer Patients
Lung Cancer
—2014-10-01
TerminatedPhase I/IIa Study to Evaluate the Safety, PK, PD, and Preliminary Efficacy of PLX8394 in Patients With Advance
Melanoma, Thyroid Cancer, Colorectal Cancer
Phase 12014-02-01
CompletedNovellusDx Tissue Collection Protocol
Patients That Have Been Diagnosed With Colorectal Cancer, Patients Eligible for Tumor Biopsy
—2014-01-01
CompletedNovellusDx Cancer Early Detection Blood Test- Clinical Trial
Lung Cancer
—2013-06-01